The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Long-Term Outcome for Patients With Nonmetastatic Osteosarcoma of the Extremity Treated at the Istituto Ortopedico Rizzoli According to the Istituto Ortopedico Rizzoli/Osteosarcoma-2 Protocol: An Updated Report
Abstract
PURPOSE: To provide an estimate of long-term prognosis for patients with osteosarcoma of the extremity treated in a single institution with neoadjuvant chemotherapy and observed for at least 10 years. PATIENTS AND METHODS: Patients with nonmetastatic osteosarcoma of the extremity were preoperatively treated with high-dose methotrexate, cisplatin, and doxorubicin (ADM). Postoperatively, good responders (90% or more tumor necrosis) received the same three drugs used before surgery, whereas poor responders (less than 90% tumor necrosis) received ifosfamide and etoposide in addition to those three drugs. RESULTS: For the 164 patients who entered the study between September 1986 and December 1989, surgery was a limb salvage in 136 cases (82%) and a good histologic response was observed in 117 patients (71%). At a follow-up ranging from 10 to 13 years (median, 11.5 years), 101 patients (61%) remained continuously free of disease, 61 relapsed, and two died of ADM-induced cardiotoxicity. There were no differences in prognosis between good and poor responding patients. ADM-induced cardiotoxicity (six patients), male infertility (10 of the 12 assessable patients), and second malignancies (seven patients) were the major complications of chemotherapy. Despite the large number of limb salvages performed, only four local recurrences (2.4%) were registered. CONCLUSION: With an aggressive neoadjuvant chemotherapy, it is possible to cure more than 60% of patients with nonmetastatic osteosarcoma of the extremity and amputation may be avoided in more than 80% of them. Because local or systemic relapses, myocardiopathies, and second malignancies are possible even 5 years or more after the beginning of treatment, a long-term follow-up is recommended for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Link, M. P., Goorin, A. M., Miser, A. W., Green, A. A., Pratt, C. B., Belasco, J. B., Pritchard, J., Malpas, J. S., Baker, A. R., Kirkpatrick, J. A., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142502 · Cited by 1,204
Rosen, G., Caparros, B., Huvos, A. G., Kosloff, C., Nirenberg, A., Cacavio, A., Marcove, R. C., Lane, J. M., Mehta, B., & Urban, C. (1982) · Cancer · doi:10.1002/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e · Cited by 1,090
The importance of dose intensity in chemotherapy of metastatic breast cancer.
Hryniuk, W., & Bush, H. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.11.1281 · Cited by 885
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers, P. A., Heller, G., Healey, J., Huvos, A., Lane, J., Marcove, R., Applewhite, A., Vlamis, V, & Rosen, G. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.1.5 · Cited by 678
Rougraff, B. T., Simon, M. A., Kneisl, J. S., Greenberg, D. B., & Mankin, H. J. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199405000-00004 · Cited by 536
Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.
Eilber, F., Giuliano, A., Eckardt, J., Patterson, K., Moseley, S., & Goodnight, J. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.1.21 · Cited by 529
Provisor, A. J., Ettinger, L. J., Nachman, J. B., Krailo, M. D., Makley, J. T., Yunis, E. J., Huvos, A. G., Betcher, D. L., Baum, E. S., Kisker, C. T., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.76 · Cited by 461
Winkler, K., Beron, G., Delling, G., Heise, U., Kabisch, H., Purfürst, C., Berger, J., Ritter, J., Jürgens, H., & Gerein, V (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.2.329 · Cited by 459
Souhami, R. L., Craft, A. W., Van der Eijken, J. W., Nooij, M., Spooner, D., Bramwell, V. H., Wierzbicki, R., Malcolm, A. J., Kirkpatrick, A., Uscinska, B. M., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02307-6 · Cited by 383
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.
Winkler, K., Beron, G., Kotz, R., Salzer-Kuntschik, M., Beck, J., Beck, W., Brandeis, W., Ebell, W., Erttmann, R., & Göbel, U. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.6.617 · Cited by 345
Fuchs, N., Bielack, S. S., Epler, D., Bieling, P., Delling, G., Körholz, D., Graf, N., Heise, U., Jürgens, H., Kotz, R., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008391103132 · Cited by 343
Bramwell, V. H., Burgers, M., Sneath, R., Souhami, R., van Oosterom, A. T., Voûte, P. A., Rouesse, J., Spooner, D., Craft, A. W., & Somers, R. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1579 · Cited by 313
Bacci, G., Picci, P., Ferrari, S., Ruggieri, P., Casadei, R., Tienghi, A., Prever, A. B. D., Gherlinzoni, F., Mercuri, M., & Monti, C. (1993) · Cancer · doi:10.1002/1097-0142(19931201)72:11<3227::aid-cncr2820721116>3.0.co;2-c · Cited by 294
Self-citationGlasser, D. B., Lane, J. M., Huvos, A. G., Marcove, R. C., & Rosen, G. (1992) · Cancer · doi:10.1002/1097-0142(19920201)69:3<698::aid-cncr2820690317>3.0.co;2-g · Cited by 282
Picci, P., Bacci, G., Campanacci, M., Gasparini, M., Pilotti, S., Cerasoli, S., Bertoni, F., Guerra, A., Capanna, R., Albisinni, U., et al. (1985) · Cancer · doi:10.1002/1097-0142(19851001)56:7<1515::aid-cncr2820560707>3.0.co;2-6 · Cited by 274
Self-citationSaeter, G., Alvegård, T. A., Elomaa, I., Stenwig, A. E., Holmström, T., & Solheim, O. P. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.10.1766 · Cited by 225
Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival
Sæter, G., Høie, J., Stenwig, A. E., Johansson, A., Hannisdal, E., & Solheim, Ø. P. (1995) · Cancer · doi:10.1002/1097-0142(19950301)75:5<1084::aid-cncr2820750506>3.0.co;2-f · Cited by 190
Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward, W. G., Mikaelian, K. A., Dorey, F. J., Mirra, J. M., Sassoon, A., Holmes, E. C., Eilber, F. R., & Eckardt, J. J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.9.1849 · Cited by 157
“Skip” metastases in osteosarcoma
Enneking, W. F., & Kagan, A. (1975) · Cancer · doi:10.1002/cncr.2820360937 · Cited by 139
Bacci, G., Ferrari, S. M., Mercuri, M., Bertoni, F., Picci, P., Manfrini, M., Gasbarrini, A., Forni, C., Cesari, M., & Campanacci, M. (1998) · Acta Orthopaedica Scandinavica · doi:10.3109/17453679809000921 · Cited by 139
Self-citationOsteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
Tabone, M., Kalifa, C., Rodary, C., Raquin, M. A., Valteau‐Couanet, D., & Lemerle, J. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.12.2614 · Cited by 137
Goorin, A. M., Shuster, J. J., Baker, A., Horowitz, M. E., Meyer, W. H., & Link, M. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.4.600 · Cited by 134
Goorin, A. M., Pérez‐Atayde, A. R., Gebhardt, M. C., Andersen, J. W., Wilkinson, R. H., Delorey, M. J., Watts, H. G., Link, M. P., Jaffe, N., & Frei, E. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.8.1178 · Cited by 125
Green, D. M., Hyland, A. J., Chung, C. S., Zevon, M. A., & Hall, B. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3207 · Cited by 121
Ferrari, S., Bacci, G., Picci, P., Mercuri, M., Briccoli, A., Pinto, D., Gasbarrini, A., Tienghi, A., & Brach del Prever, A. (1997) · Annals of Oncology · doi:10.1023/a:1008221713505 · Cited by 116
Self-citationSurgical treatment for osteosarcoma.
Springfield, D. S., Schmidt, R., Graham‐Pole, J., Marcus, R. B., Spanier, S. S., & Enneking, W. F. (1988) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198870080-00002 · Cited by 113
Late effects of therapy in adult survivors of osteosarcoma and Ewing's sarcoma
Nicholson, H. S., Mulvihill, J. J., & Byrne, J. (1992) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950200103 · Cited by 96
The contribution of salvage surgery to the management of childhood osteosarcoma.
Pastorino, U., Gasparini, M., Tavecchio, L., Azzarelli, A., Mapelli, S., Zucchi, V., Morandi, F., Bellani, F. F., Valente, M., & Ravasi, G. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.8.1357 · Cited by 80
Results of multiple pulmonary resections for metastatic osteogenic sarcoma after two decades
BEATTIE, E. J., Harvey, J. C., Marcove, R. C., & Martini, N. (1991) · Journal of Surgical Oncology · doi:10.1002/jso.2930460305 · Cited by 79
Bacci, G., Ruggieri, P., Picci, P., Briccoli, A., Ferraro, A., Ferrari, S., Tienghi, A., Iantorno, D., & Campanacci, M. (1995) · Journal of Chemotherapy · doi:10.1179/joc.1995.7.3.230 · Cited by 33
Self-citationEffects of chemotherapy on fertility
Barton, C. M., & Waxman, J. (1990) · Blood Reviews · doi:10.1016/0268-960x(90)90047-v · Cited by 30
Cited by
The Epidemiology of Osteosarcoma
Ottaviani, G., & Jaffe, N. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,786
Osteosarcoma treatment – Where do we stand? A state of the art review
Luetke, A., Meyers, P. A., Lewis, I., & Juergens, H. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.006 · Cited by 1,234
Smeland, S., Bielack, S. S., Whelan, J., Bernstein, M., Hogendoorn, P., Krailo, M. D., Gorlick, R., Janeway, K. A., Ingleby, F. C., Anninga, J., et al. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2018.11.027 · Cited by 704
Primary bone osteosarcoma in the pediatric age: State of the art
Longhi, A., Errani, C., De Paolis, M., Mercuri, M., & Bacci, G. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.05.005 · Cited by 631
Self-citationOsteosarcoma (Osteogenic sarcoma)
Picci, P. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-6 · Cited by 505
Self-citation
Metadata
- Authors
- Bacci, G., Ferrari, S., Bertoni, F., Ruggieri, P., Picci, P., Longhi, A., Casadei, R., Fabbri, N., Forni, C., Versari, M., & Campanacci, M.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-12-15
- Volume
- 18
- Issue
- 24
- Pages
- 4016-4027
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1924934937
- Cited by
- 438
- References
- 32
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.